title: Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001.
abstract: A cohort of 9919 breast cancer patients from the population-based Eindhoven Cancer Registry was followed for vital status and development of second cancer. Person-year analysis was applied to determine the risk of second primary breast or urogenital cancer among breast cancer patients and to assess its correlation with age, treatment and time since the first breast cancer diagnosis. Women with previous breast cancer have an elevated risk of overall second breast or urogenital cancer. The largest relative risk was observed for second breast cancer (SIR (standardised incidence ratio) 3.5; 95% confidence interval (CI) 3.2-3.8) and second ovarian cancer (SIR 1.7; 95% CI 1.2-2.3). The absolute excess risk was highest for second breast cancer (64/10,000 patients/year). However, breast cancer has an inverse relationship to risk of cervical cancer. Changes in behavioural risk factors are important for lowering the risk of second cancer after breast cancer.
authors.affiliation: Netherlands Institute of Health Sciences, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
authors.forename: I
authors.initials: I
authors.lastname: Soerjomataram
authors.forename: W J
authors.initials: WJ
authors.lastname: Louwman
authors.forename: V E P P
authors.initials: VE
authors.lastname: Lemmens
authors.forename: E
authors.initials: E
authors.lastname: de Vries
authors.forename: W J
authors.initials: WJ
authors.lastname: Klokman
authors.forename: J W W
authors.initials: JW
authors.lastname: Coebergh
mesh_terms: D000328:Adult; D017677:Age Distribution; D017668:Age of Onset; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000628:therapy; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D009426:Netherlands / Q000453:epidemiology; D012307:Risk Factors; D013997:Time Factors; D014565:Urogenital Neoplasms / Q000453:epidemiology* / Q000628:therapy